37982 Federal Register / Vol. 65, No. 118 / Monday, June 19, 2000 / Notices

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[30DAY–41–00]

Agency Forms Undergoing Paperwork

Reduction Act Review

The Centers for Disease Control and

Prevention (CDC) publishes a list of

information collection requests under

review by the Office of Management and

Budget (OMB) in compliance with the

Paperwork Reduction Act (44 U.S.C.

Chapter 35). To request a copy of these

requests, call the CDC Reports Clearance

Officer at (404) 639–7090. Send written

comments to CDC, Desk Officer; Human

Resources and Housing Branch, New

Executive Office Building, Room 10235;

Washington, DC 20503. Written

comments should be received within 30

days of this notice.

Proposed Projects

National Hospital Ambulatory

Medical Care Survey—0920–0278)—

Revision—(NCHS)—The National

Hospital Ambulatory Medical Care

Survey (NHAMCS) has been conducted

annually since 1992 and is directed by

the Division of Health Care Statistics,

National Center for Health Statistics,

Centers for Disease Control and

Prevention. The purpose of the

NHAMCS is to meet the needs and

demands for statistical information

about the provision of ambulatory

medical care services in the United

States. Ambulatory services are

rendered in a wide variety of settings,

including physicians’ offices and

hospital outpatient and emergency

departments. The target universe of the

NHAMCS is in-person visits made in

the United States to outpatient

departments and emergency

departments of non-Federal, short-stay

hospitals (hospitals with an average

length of stay of less than 30 days) or

those whose specialty is general

(medical or surgical) or children’s

general. The NHAMCS was initiated to

complement the National Ambulatory

Medical Care Survey (NAMCS, OMB

No. 0920–0234) which provides similar

data concerning patient visits to

physicians’ offices. The NAMCS and

NHAMCS are the principal sources of

data on approximately 90 percent of

ambulatory care provided in the United

States.

The NHAMCS provides a range of

baseline data on the characteristics of

the users and providers of ambulatory

medical care. Data collected include

patients’ demographic characteristics

and reason(s) for visit, and the

physicians’ diagnosis(es), diagnostic

services, medications, and disposition.

These data, together with trend data,

may be used to monitor the effects of

change in the health care system, the

planning of health services, improving

medical education, determining health

care work force needs, and assessing the

health status of the population.

Users of NHAMCS data include, but

are not limited to, congressional offices,

Federal agencies such as NIH, state and

local governments, schools of public

health, colleges and universities, private

industry, nonprofit foundations,

professional associations, as well as

individual practitioners, researchers,

administrators, and health planners.

Uses vary from the inclusion of a few

selected statistics in a large research

effort, to an in-depth analysis of the

entire NHAMCS data set covering

several years.

The number of respondents for the

NHAMCS is based on a sample of 600

hospitals with an 87 percent

participation rate. The total annual

burden hours is 13.450.

Form name Number of

respondents

Number of

responses

Avg. burden

per response

(hours)

Total Burden

(in hours)

Hospital Induction (NHAMCS–101):

Ineligible .................................................................................................... 65 1 15/60 16

Eligible ...................................................................................................... 535 1 70/60 624

Ambulatory Unit Induction (ED) (NHAMCS–101/U) ........................................ 435 1 1 435

Ambulatory Unit Induction (OPD) (NHAMCS–101/U) ..................................... 300 4 1 1,200

ED Patient Record Form ................................................................................. 435 100 5/60 3,625

OPD Patient Record Form .............................................................................. 300 300 5/60 7,500

Nonresponse study .......................................................................................... 50 1 1 50

Total .......................................................................................................... ........................ ........................ ........................ 13,450

Dated: June 14, 2000.

Charles W. Gollmar,

Acting Associate Director for Policy, Planning

and Evaluation, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 00–15458 Filed 6–16–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Program Announcement 00120]

West Nile Virus Surveillance Notice of

Availability of Funds

A. Purpose

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 2000

funds for a cooperative agreement

program for West Nile Virus

Surveillance. This program addresses

the ‘‘Healthy People 2010’’ focus area

Immunization and Infectious Diseases.

For a conference copy of ‘‘Healthy

People 2010’’, visit the internet site:

<http://www.health.gov/healthypeople>

The purpose of the program is to

assist states in developing and

implementing dead bird and human/

equine encephalitis surveillance

activities focusing on West Nile (WN)

Virus.

The WN fever outbreak in the

northeastern United States (U.S.) in the

summer and fall of 1999, represented

the first incursion of this exotic

arbovirus into the U.S. As of December

9, 1999, 62 confirmed or probable

human cases of WN virus infection had

been identified, including seven deaths.

The basic transmission cycle of WN

fever involves mosquitoes feeding on

birds infected with the WN virus.

Infected mosquitoes then transmit WN

Federal Register / Vol. 65, No. 118 / Monday, June 19, 2000 / Notices 37983

virus to humans and animals. This virus

outbreak occurred during the peak

southerly bird migration, and the effect

this migration had on the spread of the

virus beyond the outbreak epicenter is

unknown. Additional information may

be found in 3 MMWR articles (attached

in the application package).

B. Eligible Applicants

Assistance will be provided only to

state health departments in the

contiguous 48 states that are not

currently receiving or eligible for WN

funding through other CDC cooperative

agreement programs. Thus, the

following five states are eligible to apply

for these funds under this

announcement:

Arkansas, Idaho, Nevada, New

Hampshire, and North Dakota.

No other applications are solicited.

All other state health departments in

the contiguous 48 states are receiving or

are eligible for WN surveillance funding

in FY 2000 through other CDC programs

including the Epidemiology and

Laboratory Capacity (ELC) for Infectious

Diseases, the Emerging Infections

Program (EIP), and the Council for State

and Territorial Health Departments

(CSTE) cooperative agreements.

Note: Public Law 104–65 states that an

organization described in section 501(c)(4) of

the Internal Revenue Code of 1986 that

engages in lobbying activities is not eligible

to receive Federal funds constituting an

award, grant, cooperative agreement,

contract, loan, or any other form.

C. Availability of Funds

Approximately $450,000 is available

in FY 2000 to fund five awards. It is

expected that each approved applicant

will receive an award not exceeding

$90,000 (including direct and indirect

costs). It is expected that the awards

will begin on or about August 1, 2000

and will be made for a 12-month budget

period within a project period of one

year. Funding estimates may change.

D. Program Requirements

In conducting activities to achieve the

purpose of this program, the recipient

will be responsible for the activities

under Recipient Activities, and CDC

will be responsible for conducting

activities under CDC Activities:

Recipient Activities

1. Develop or enhance dead bird and

human/equine encephalitis surveillance

activities, focusing on WN virus.

Activities should be consistent with

published CDC guidelines entitled

Epidemic/Epizootic West Nile Virus in

the United States: Guidelines for

Surveillance, Prevention and Control,

March 2000—available via the CDC Web

site at: http://www.cdc.gov/ncidod/

dvbid/ arbor/

WN_surv_guide_Mar_2000.pdf

2. Conduct data analysis and interpret

and disseminate results.

3. If proposed activities involve

research on human participants, ensure

appropriate Institutional Review Board

(IRB) review.

CDC Activities

1. Provide overall multi-site project

coordination.

2. Provide technical support in the

design, implementation, and evaluation

of program activities, if requested.

3. Assist in data analysis and

dissemination of project findings as

needed.

4. If during the project period research

involving human subjects should be

conducted and CDC scientists will be

co-investigators in that research, assist

in the development of a research

protocol for IRB review by all

institutions participating in the research

project. The CDC IRB will review and

approve the protocol initially and on at

least an annual basis until the research

project is completed.

E. Application Content

Use the information in the Program

Requirements, Other Requirements, and

Evaluation Criteria sections to develop

the application content. Applications

will be evaluated on the criteria listed

in Section G., below, so it is important

that narratives clearly address the

criteria.

The narratives should be no more

than 5 single-spaced pages along with a

separate line-item budget and

justification.

As indicated in the Availability of

Funds section above, the maximum

award to any single applicant will be

$90,000 (including direct and indirect

costs). Do NOT submit a budget for any

more than $90,000 total. A budget

justification is required for all budget

items and must be submitted with

Standard Form 424A, ‘‘Budget

Information,’’ as part of the CDC

application Form 0.1246(E). If

requesting funds for any contractual

activities, provide the following

information for each contract or

subaward: (1) Name of proposed

contractor, (2) breakdown and

justification for estimated costs, (3)

description and scope of activities to be

performed by contractor, (4) period of

performance, (5) method of contractor

selection (e.g., sole-source or

competitive solicitation), and (6)

method of accountability.

All pages of the applications must be

single-spaced, printed on one side, with

one inch margins and a font size of 12

on white 8.5′′ x 11′′ paper.

The required original application and

two full copies must be submitted

unstapled and unbound. Do not submit

any bound or stapled materials (e.g.,

pamphlets, booklets, etc.) in the

appendices. The entire application must

be able to run through an automatic

document feed copier.

F. Submission and Deadline

Application

Submit the original and two copies of

CDC 0.1246. Forms are available in the

application kit. On or before July 12,

2000, submit the application to the

Grants Management Specialist

identified in the ‘‘Where to Obtain

Additional Information’’ section of this

announcement.

Deadline: Applications shall be

considered as meeting the deadline if

they are either:

(a) Received on or before the deadline

date; or

(b) Sent on or before the deadline date

and received in time for submission to

the independent review group.

(Applicants must request a legibly dated

U.S. Postal Service postmark or obtain

a legibly dated receipt from a

commercial carrier or U.S. Postal

Service. Private metered postmarks shall

not be acceptable as proof of timely

mailing.)

Late Applications: Applications

which do not meet the criteria in (a) or

(b) above are considered late

applications, will not be considered,

and will be returned to the applicant.

G. Evaluation Criteria

Each application will be evaluated

individually against the following

criteria by an independent review group

appointed by CDC:

1. Objectives (40 points): The extent

to which the objectives for the project

are clear and consistent with the

purpose and Program Requirements of

this cooperative agreement

announcement.

2. Operational Plan (60 points): The

extent to which the operational plan is

clear and appropriate to achieve the

stated objectives, identifies the key

personnel and organizations responsible

for the proposed activities, and

identifies a specific timetable for

activities. If proposed activities involve

research on human participants, the

degree to which the applicant has met

the CDC Policy requirements regarding

the inclusion of women, ethnic, and

racial groups in the proposed research.

37984 Federal Register / Vol. 65, No. 118 / Monday, June 19, 2000 / Notices

This includes: (a) The proposed plan for

the inclusion of both sexes and racial

and ethnic minority populations for

appropriate representation; (b) The

proposed justification when

representation is limited or absent; (c) A

statement as to whether the design of

the study is adequate to measure

differences when warranted; (d) A

statement as to whether the plans for

recruitment and outreach for study

participants include the process of

establishing partnerships with

community(ies) and recognition of

mutual benefits.

3. Budget (not scored): The extent to

which the project budget includes

detailed line-item justification and is

appropriate for the activities proposed.

4. Human Subjects (not scored): If

proposed activities involve research on

human participants, does the

application adequately address the

requirements of Title 45 CFR Part 46 for

the protection of human subjects?

H. Other Requirements

Technical Reporting Requirements

Provide CDC with original plus two

copies of

1. Mid-program period progress report

(due 6 months after award date);

2. financial status report, no more

than 90 days after the end of the budget/

project period; and

3. final performance report, no more

than 90 days after the end of the budget/

project period.

Send all reports to the Grants

Management Specialist identified in the

‘‘Where to Obtain Additional

Information’’ section of this

announcement.

The following additional

requirements are applicable to this

program. For a complete description of

each, sees Attachment I in the

application kit.

AR–1 Human Subjects Requirements

AR–2 Requirements for Inclusion of

Women and Racial and Ethnic

Minorities in Research

AR–7 Executive Order 12372 Review

AR–10 Smoke–Free Workplace

Requirements

AR–11 Healthy People 2010

AR–12 Lobbying Restrictions

I. Authority and Catalog of Federal

Domestic Assistance Number

This program is authorized under the

Public Health Service Act Sections

301(a)[42 U.S.C. 241(a)] and

317(k)(2)[42 U.S.C. 247b(k)(2)], as

amended. The Catalog of Federal

Domestic Assistance number is 93.283.

J. Where To Obtain Additional

Information

To obtain additional information,

contact: Andrea Wooddall, Grants

Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention, Room 3000,

2920 Brandywine Road, Atlanta, GA

30341–4146, Telephone number: (770)

488–2749, Email address:

AWooddall@cdc.gov.

For program technical assistance,

contact: John T. Roehrig, Ph.D.,

Arbovirus Diseases Branch, Division of

Vector-Borne Infectious Diseases,

National Center for Infectious Diseases,

Centers for Disease Control and

Prevention (CDC), P. O. Box 2087

(Mailstop P02), Fort Collins, CO 80522,

Telephone number: (970) 221–6465;

Fax: (970) 221–6476, Email:

jtr1@cdc.gov.

Attachments (The following articles

are included in the mailed application

kit):

Attachment II: MMWR, Outbreak of

West Nile-Like Viral Encephalitis—

New York, 1999. October 1, 1999/

48(38);845–9.

Attachment III: MMWR, Update: West

Nile-Like Viral Encephalitis—New

York, 1999. October 8, 1999/

48(39);890–2.

Attachment IV: MMWR, Update: West

Nile Virus Encephalitis—New York,

1999. October 22, 1999/48(41);944–

946, 955.

Dated: June 13, 2000.

John L. Williams,

Director, Procurement and Grants Office,

Centers for Disease Control and Prevention

(CDC).

[FR Doc. 00–15372 Filed 6–16–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Administration for Children and

Families

Proposed Information Collection

Activity; Comment Request

Proposed Projects

Title: Runaway and Homeless Youth

Program Regulations—Final Rule.

OMB No.: New Collection.

Description: The Runaway and

Homeless Youth program is

administered by the Family and Youth

Services Bureau (FYSB). The

authorizing legislation for the Runaway

and Homeless Youth (RHY) Program,

Pub. L. 106–71 (42 U.S.C. 5701), Section

311, set forth provisions for awarding

grants through a competitive process to

public and nonprofit private entities

(and combinations of such entities) to

establish and operate local programs to

provide services for runaway and

homeless youth and for their families.

For the competitive grant making

process, eligible entities are required to

describe their goals, plans (scope of

activities), capacities and other

qualifications for receiving Federal

funding to operate the type of youth

services programs authorized under the

RHY Act. The detailed information is

collected via the Uniform Project

Description (UPD), OMB control

number 0970–0139. The UPD

information collected is the basis for

determining the most appropriate

entities for grant funding. Basic

organizational and summary budget

information required by OMB circular

A–102 as part of an ‘‘Application for

Federal Assistance’’ is also collected via

the SF–424 (OMB control number 0348–

0043), the SF–424A (OMB control

number 0348–0044), the SF–424B (OMB

control number 0348–0040) and the

‘‘Disclosure of Lobbying Activities’’ SF–

LLL (OMB number 0348–0046). The

information is requested annually

through the RHY Program

Announcement. The program

regulations implementing provisions of

the RHY Act limit grants project periods

to three years (a limit not specified in

the statue). The final rule would change

the project periods from a maximum of

three years to five years. The regulation

change is technical in nature and will

allow FYSB the flexibility and

discretion to award some grants for fiveyear periods, instead of three years. The

regulatory change will not increase the

burden for any entities. The change will

only affect the frequency of application

submission.

Respondents: Community-based

Organizations, States, and Tribes.